Tremendous activity in recent months, including receipt of Japanese marketing approval, the fifth parallel U.S. trial ...
Compounds found in cannabis could provide a new roadmap for treating the world’s most common chronic liver disorder, according to a study released by the Hebrew University of Jerusalem.
X-TOLE2 met primary endpoint in both dose groups, including -53.2% median percent change (MPC) from baseline in monthly FOS frequency with 25 mg ...
Multivitamins are the most common dietary supplement in the U.S. People take these pills (or gummies, indeed) for a variety of health reasons, but the science on what multivitamins may do for your ...
CDI-988 is a direct-acting, oral antiviral being developed for norovirusNorovirus challenge study is underway at Emory ...
New platform connects patients with licensed providers offering sermorelin under medical supervision, supported by a growing body of peer-reviewed research and an emerging community of clinicians and ...
Scientists at Brigham and Women’s Hospital and others studied thousands of older adults who were asked to take a daily multivitamin and multimineral supplement. They found evidence that daily ...
New research suggests that an existing blood test may help to determine when someone is likely to develop Alzheimer's disease ...
Initial MGC028 (ADAM9 ADC) Phase 1 results in second half of 2026Lorigerlimab Phase 2 LINNET study update in mid-2026IND ...
LOQTORZI® net revenue more than doubled to $40.8 million in 2025 from $19.1 million in 2024 – – Reduced secured and convertible debt by 90% from $480 million to $38.8 million over 2024-2025 – – $172.1 ...
Positive data from EXPERTS-ALS could accelerate RT1999 towards a registration trial; RT1999 to be presented as a poster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results